TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 156,304,502 | 111,236,771 | 112,386,688 |
Financial expenses | 1,440,625 | 454,454 | 1,050,744 |
Earnings before taxes | -19,544,448 | 22,450,590 | 37,840,414 |
EBITDA | 27,952,665 | 25,079,790 | 39,204,391 |
Total assets | 255,456,014 | 308,233,607 | 332,187,101 |
Current assets | 31,933,066 | 31,163,226 | 25,073,294 |
Current liabilities | 23,601,467 | 19,757,027 | 24,851,203 |
Equity capital | 200,068,287 | 255,061,274 | 274,160,161 |
- share capital | 1,942,905 | 2,003,106 | 2,151,773 |
Employees (average) | 6,875 | 6,814 | 6,633 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 78.3% | 82.7% | 82.5% |
Turnover per employee | 22,735 | 16,325 | 16,944 |
Profit as a percentage of turnover | -12.5% | 20.2% | 33.7% |
Return on assets (ROA) | -7.1% | 7.4% | 11.7% |
Current ratio | 135.3% | 157.7% | 100.9% |
Return on equity (ROE) | -9.8% | 8.8% | 13.8% |
Change turnover | 48,410,865 | 6,614,932 | 20,754,033 |
Change turnover % | 45% | 6% | 23% |
Chg. No. of employees | 61 | 181 | 483 |
Chg. No. of employees % | 1% | 3% | 8% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.